RUIXIN REGENERATIVE

Ruirui Regeneration is a small molecule pharmaceutical R&D manufacturer dedicated to the development of new technologies for somatic cell reprogramming and regenerative medicine. The development of small molecule drugs reverses tissue and organ fibrosis and achieves in situ regeneration of functional cells for chronic heart failure and liver. The treatment of a variety of major diseases that are difficult to cure, such as aging, provides a completely new solution.